Search results for: Precision Medicine
Filter search results
The Dynamics of Drug Shortages
9 January 2024
…lead to a shortage. An example of this is in the USA, where several cancer medicines have been in shortage for several years due to manufacturing and supply chain issues…
Value Based Pricing in the UK
7 September 2010
…therapies, particularly new medicines. Health technology assessment, he believes, is an important tool, but only if used appropriately and within its limits. In the UK, prices for medicines are guided…
Drugs and Vaccines for Developing Countries
1 June 2011
…of the Biopharmaceutical Industry. The authors describe the context of the problem of insufficient affordable medicines in developing countries and detail policies and proposals intended to increase access to global medicines…
Policy Options for Formulary Development in Middle-income Countries
1 January 2017
…medicines for formulary inclusion. This report presents a framework for developing medicines formularies which combines macro-level decision making factors (focusing on the health system organisation and its priority setting), and…
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
…perspective of the experience of the economic regulation of other industries in the UK, notably the privatised utilities. Share this: Download publication The NHS procures medicines in a variety of…
Measuring the Benefits of Medicines: The Future Agenda
1 March 1990
…of cost effectiveness in medical care. Now in 1990 the industry is still ahead in undertaking economic analyses to demonstrate the fact that its medicines are often the most economical…
Victoria Jordan
21 January 2026
…in Economic Evaluation for HTA, Health Economics from the University of York and enjoys bringing together advances in medicines evaluation methods and processes with the practicalities of getting new medicines…
Dr Francois Maignen joins the OHE team as Head of Operational Research and Data Analysis
7 July 2016
…Data Analysis. Francois’s principal areas of expertise are in the clinical development (methodology of clinical trials) and regulation of medicines for human use. Francois worked at the European Medicines…
Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study
1 January 2017
…framework for developing medicines formularies which combines macro-level decision… PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for…